Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.81B | 2.52B | 2.08B | 1.73B | 1.43B | 1.02B |
Gross Profit | 2.01B | 924.63M | 756.52M | 596.21M | 441.15M | 360.06M |
EBITDA | 733.18M | 598.63M | 497.60M | 418.32M | 186.62M | 235.58M |
Net Income | 55.68M | 94.67M | 61.04M | 163.26M | 65.87M | 68.10M |
Balance Sheet | ||||||
Total Assets | 10.63B | 9.65B | 7.25B | 6.38B | 5.46B | 4.53B |
Cash, Cash Equivalents and Short-Term Investments | 172.59M | 540.20M | 838.79M | 992.72M | 386.96M | 312.65M |
Total Debt | 3.65B | 3.46B | 2.16B | 2.16B | 1.68B | 1.69B |
Total Liabilities | 9.44B | 8.55B | 6.27B | 5.57B | 4.86B | 4.46B |
Stockholders Equity | 610.09M | 627.66M | 559.75M | 478.40M | 343.77M | 69.79M |
Cash Flow | ||||||
Free Cash Flow | 510.40M | 467.87M | 447.43M | 320.47M | 263.71M | 122.89M |
Operating Cash Flow | 571.34M | 514.87M | 477.20M | 335.51M | 273.49M | 135.39M |
Investing Cash Flow | -2.14B | -1.76B | -476.23M | -22.42M | -457.94M | -865.42M |
Financing Cash Flow | 1.33B | 1.17B | -12.61M | 314.76M | 429.28M | 989.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $6.24B | 9.24 | 12.94% | 1.91% | 4.79% | -0.76% | |
77 Outperform | $6.54B | 9.30 | 14.85% | 1.87% | 3.26% | 12.70% | |
77 Outperform | $10.57B | 15.16 | 13.65% | 1.50% | 6.42% | -7.74% | |
74 Outperform | $16.16B | 15.07 | 14.20% | 3.33% | 7.25% | 17.55% | |
68 Neutral | $13.63B | 2,216.52 | 9.44% | 0.91% | 22.21% | -30.67% | |
68 Neutral | $18.10B | 11.52 | 9.93% | 3.73% | 9.70% | 1.14% | |
65 Neutral | $6.93B | 36.57 | 3.80% | 3.18% | 14.28% | -2.87% |
On September 3, 2025, Ryan Specialty Holdings, Inc. appointed Michael G. Bungert, a veteran in the (re)insurance industry, to its Board of Directors and its Compensation and Governance Committee. Mr. Bungert, who has extensive experience in the insurance sector, is expected to bring strategic insights to the company. His appointment is seen as a move to strengthen Ryan Specialty’s position as a leader in the specialty insurance market, with Mr. Bungert’s experience anticipated to contribute to the firm’s innovative solutions and forward momentum.
Ryan Specialty Holdings, Inc. reported a strong financial performance for the second quarter of 2025, with total revenue increasing by 23.0% year-over-year to $855.2 million. The company achieved a net income of $124.7 million and an adjusted EBITDAC growth of 24.5%, reflecting its resilience in a challenging property rate environment. The firm also completed three acquisitions, bolstering its market position and demonstrating its commitment to long-term growth and value creation for shareholders.
On July 16, 2025, Ryan Specialty Holdings, Inc. announced the passing of D. Cameron Findlay, a long-serving director and Chairperson of the Compensation and Governance Committee. Mr. Findlay, who had been with the company since 2012, was remembered for his extensive experience and contributions to the firm. In response to his passing, John W. Rogers, Jr. was appointed as Lead Director and Henry S. Bienen as Chairperson of the Compensation and Governance Committee. The announcement reflects the company’s efforts to address leadership changes while honoring Mr. Findlay’s legacy.